Last Updated: April 23, 2026

Claims for Patent: 11,278,615

✉ Email this page to a colleague

Summary for Patent: 11,278,615

Title:	Mixed allergen compositions and methods for using the same
Abstract:	Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications.
Inventor(s):	Kari C. Nadeau
Assignee:	Leland Stanford Junior University
Application Number:	US17/239,252

Details for Patent 11,278,615

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Modernatx, Inc.	SPIKEVAX	covid-19 vaccine, mrna	Injection	125752	January 31, 2022	⤷ Start Trial	2041-04-23
Modernatx, Inc.	SPIKEVAX	covid-19 vaccine, mrna	Injection	125752	September 11, 2023	⤷ Start Trial	2041-04-23
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,278,615

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2016219793	⤷ Start Trial
Australia	2022201699	⤷ Start Trial
Brazil	112017017894	⤷ Start Trial
Canada	2977127	⤷ Start Trial
China	107405394	⤷ Start Trial
China	114129720	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.